Effectiveness of a single-day three-drug regimen of dexamethasone, palonosetron, and aprepitant for the prevention of acute and delayed nausea and vomiting caused by moderately emetogenic chemotherapy

被引:0
作者
Steven M. Grunberg
Matthew Dugan
Hyman Muss
Marie Wood
Susan Burdette-Radoux
Tracey Weisberg
Marisa Siebel
机构
[1] Vermont Cancer Center,Division of Hematology/Oncology
[2] Maine Center for Cancer Medicine,undefined
[3] Stonybrook University Hospital,undefined
来源
Supportive Care in Cancer | 2009年 / 17卷
关键词
Palonosetron; Aprepitant; Dexamethasone; Antiemetic;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 101 条
  • [11] Van Belle S(2007)Antiemesis J Natl Compr Canc Netw 5 12-33
  • [12] Reinhardt RR(2003)Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron Ann Oncol 14 1570-1577
  • [13] Cohen L(1996)On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993 Ann Oncol 7 189-195
  • [14] de Moor CA(2006)Combination therapy for chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: palonosetron, dexamethasone, and aprepitant J Support Oncol 4 403-408
  • [15] Eisenberg P(2004)Incidence of chemotherapy-induced nausea and emesis after modern antiemetics Cancer 100 2261-2268
  • [16] De Jongh Garcia C(2008)How familiar are oncologists with therapeutic care and supportive care guidelines? Support Care Cancer 16 631-632
  • [17] Poli S(2008)Randomized, placebo-controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy-induced nausea and vomiting Cancer 112 2080-2087
  • [18] Ananth C(2003)The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin—the Aprepitant Protocol 052 Study Group J Clin Oncol 21 4112-4119
  • [19] De Wit R(2003)Treatment options for chemotherapy-induced nausea and vomiting: current and future Am J Cancer 2 391-392
  • [20] Eisenberg P(2008)Frequency and predictors of prescription-related issues after hospital discharge J Hosp Med 3 12-19